angiotensin ii has been researched along with benazepril in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (15.63) | 18.7374 |
| 1990's | 10 (31.25) | 18.2507 |
| 2000's | 11 (34.38) | 29.6817 |
| 2010's | 5 (15.63) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, Y; Inukai, T; Kuroda, K; Nakao, K | 1 |
| Bellet, M; Brunner, J; Juillerat, L; Ménard, J; Nussberger, J; Perret, F; Waeber, B | 1 |
| Brunner, HR; Nussberger, J; Waeber, B | 1 |
| Bellet, M; Corvol, P; Guyene, TT; Ménard, J; Sassano, P; Serrurier, D | 1 |
| Bidiville, J; Brunner, HR; Bussien, JP; Nussberger, J; Porchet, M; Waeber, B | 1 |
| Brunner, H; Brunner, HR; Bussien, JP; Nussberger, J; Schaller, MD; Turini, GA; Waeber, B | 1 |
| Criscione, L; Dohi, Y; Lüscher, TF; Pfeiffer, K | 1 |
| Battle, T; Bunkenburg, B; Heudes, D; Ménard, J; Schnell, C; Wood, JM | 1 |
| Allegrini, P; Baum, HP; Cumin, F; de Gasparo, M; Drexler, H; Kästner, S; Laurent, D; Studer, R; Whitebread, S; Zierhut, W | 1 |
| Brands, MW; Gardner, A; Hall, JE; Harrison, DL; Keen, HL; Shek, EW | 1 |
| Carugo, S; Cattaneo, BM; Grassi, G; Lanfranchi, A; Mancia, G; Morganti, A; Pozzi, M; Seravalle, G | 1 |
| Brands, MW; Hall, JE; Keen, HL; Smith, MJ | 1 |
| Li, J; Wang, H; Yu, L; Zhou, C | 1 |
| Cao, H; Ke, YS; Yang, T | 1 |
| Imai, H; Inoue, T; Ishida, Y; Nakamoto, H; Okada, H; Suzuki, H; Yamanouchi, Y | 1 |
| Li, J; Wang, H; Zhou, C | 1 |
| Ke, YS; Tao, YY; Yang, H; Yu, GH | 1 |
| Dong, J; Liu, X; Lv, Y; Niu, X | 1 |
| Liu, GS; Wang, H; Xue, H; Zhang, YL | 1 |
| Arsenault, D; Battistini, B; Beaudoin, M; Belleville, K; Benrezzak, O; Blouin, A; Cayer, J; Daull, P; Jeng, AY; Nantel, F; Pheng, LH; Sirois, P | 1 |
| Siragy, HM; Webb, RL; Xue, C | 1 |
| Liu, Y; Meng, QH; Wang, L; Zhu, S | 1 |
| Mishina, M; Watanabe, T | 1 |
| Baker, KM; Khode, R; Kumar, R; Le, B; Singh, VP | 1 |
| Liu, XP; Pang, YJ; Sun, SJ; Sun, ZJ; Wang, YB; Zhao, TT; Zheng, M; Zhu, WW | 1 |
| Homma, S; Muchir, A; Sera, F; Worman, HJ; Wu, W | 1 |
| Danhof, M; Fink, M; Giraudel, JM; Mochel, JP; Peyrou, M; Soubret, A | 1 |
| Chen, J; Hu, YJ; Peng, DF; Tang, SY | 1 |
| Jiang, L; Liang, ZG; Lin, X; Yao, H | 1 |
| Du, YP; Peng, YG; Shi, GX; Shi, Y; Su, H; Sun, CF; Wang, SG; Wang, YK; Wen, T | 1 |
| Domenig, O; Gabriel, V; Guillot, E; Iennarella-Servantez, CA; Mochel, JP; Smith, JS; Sotillo, S; Ward, JL; Yuan, L | 1 |
1 review(s) available for angiotensin ii and benazepril
| Article | Year |
|---|---|
The present molecules of converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Bridged Bicyclo Compounds; Captopril; Cilazapril; Cyclopentanes; Dipeptides; Enalapril; Humans; Indoles; Lisinopril; Perindopril; Pyridazines; Ramipril; Renin-Angiotensin System | 1985 |
8 trial(s) available for angiotensin ii and benazepril
| Article | Year |
|---|---|
Need for plasma angiotensin measurements to investigate converting-enzyme inhibition in humans.
Topics: Administration, Oral; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Clinical Trials as Topic; Enalapril; Humans | 1989 |
Crossover design for the dose determination of an angiotensin converting enzyme inhibitor in hypertension.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure Determination; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Patient Compliance; Renin | 1989 |
[ACE-inhibitors indicated even in non-diabetic nephropathy].
Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Female; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies | 1996 |
Effects of valsartan with or without benazepril on blood pressure, angiotensin II, and endoxin in patients with essential hypertension.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Cardenolides; Digoxin; Female; Humans; Hypertension; Male; Middle Aged; Saponins; Tetrazoles; Valine; Valsartan | 2003 |
Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker.
Topics: Administration, Inhalation; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Double-Blind Method; Female; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Prospective Studies; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan | 2008 |
Development of hypertension and effects of benazepril hydrochloride in a canine remnant kidney model of chronic renal failure.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Dog Diseases; Dogs; Female; Hypertension; Kidney Failure, Chronic; Male; Renin | 2008 |
Fluvastatin combined with benazepril may contribute to the favorable prognosis of patients with atrial fibrillation.
Topics: Angiotensin II; Atrial Fibrillation; Benzazepines; C-Reactive Protein; Case-Control Studies; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heart Function Tests; Humans; Indoles; Interleukin-6; Kidney; Liver; Male; Middle Aged; Prognosis; Renin; Treatment Outcome; Tumor Necrosis Factor-alpha | 2016 |
Dose-response of benazepril on biomarkers of the classical and alternative pathways of the renin-angiotensin-aldosterone system in dogs.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Dogs; Renin-Angiotensin System | 2023 |
23 other study(ies) available for angiotensin ii and benazepril
| Article | Year |
|---|---|
Antihypertensive mechanism of action of the novel angiotensin converting enzyme inhibitor benazepril. Effect on isolated vascular preparations.
Topics: Alprostadil; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzazepines; Bradykinin; Dinoprost; Dinoprostone; Epoprostenol; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Potassium; Rabbits; Rats; Rats, Inbred Strains; Serotonin | 1990 |
Effect of eight-day converting enzyme inhibition on ambulatory blood pressure recordings in normotensive volunteers.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Cilazapril; Humans; Indoles; Male; Perindopril; Pyridazines | 1987 |
Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Hemodynamics; Humans; Male; Renin | 1985 |
Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries.
Topics: Acetylcholine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Disease Models, Animal; Endothelins; Endothelium, Vascular; Hypertension; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Potassium Chloride; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Tetrazoles; Vascular Resistance | 1994 |
Continuous versus intermittent angiotensin converting enzyme inhibition in renal hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Creatinine; Fibrosis; Heart Rate; Hypertension, Renovascular; Kidney; Male; Myocardium; Organ Size; Rats; Rats, Wistar; Renin; Urea | 1993 |
Left ventricular wall stress and sarcoplasmic reticulum Ca(2+)-ATPase gene expression in renal hypertensive rats: dose-dependent effects of ACE inhibition and AT1-receptor blockade.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Benzazepines; Blotting, Northern; Calcium-Transporting ATPases; Dose-Response Relationship, Drug; Heart Ventricles; Hypertension, Renal; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Rats; Rats, Inbred WKY; Sarcoplasmic Reticulum; Tetrazoles; Valine; Valsartan | 1996 |
Insulin-induced hypertension in rats depends on an intact renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Glomerular Filtration Rate; Hypertension; Insulin; Male; Natriuresis; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Time Factors | 1997 |
Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Baroreflex; Benzazepines; Blood Pressure; Coronary Circulation; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Pressoreceptors; Renin; Sympathetic Nervous System | 1997 |
Maintenance of baseline angiotensin II potentiates insulin hypertension in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Drug Synergism; Glucose; Hypertension; Insulin; Kidney; Male; Rats; Rats, Sprague-Dawley; Renal Circulation; Thromboxane B2; Vascular Resistance | 1998 |
Renal protective effects of blocking the intrarenal renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Doxorubicin; Glomerulonephritis; Kidney; Male; Nephrectomy; Nephrotic Syndrome; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Transforming Growth Factor beta | 1999 |
Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Drug Therapy, Combination; Hypertension; Hypertrophy, Left Ventricular; Male; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Valine; Valsartan | 2000 |
Renin-angiotensin system plays an important role in the regulation of water transport in the peritoneum.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aquaporins; Benzazepines; Biological Transport; Body Water; Dialysis Solutions; Fluorescent Antibody Technique; Glucose; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2001 |
[The effects of blocking intrarenal renin-angiotensin system on the expression of transforming growth factor-beta1 mRNA and extracellular matrix components].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Doxorubicin; Extracellular Matrix Proteins; Glomerulonephritis; Kidney; Male; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 1999 |
Renoprotective effect of benazepril on diabetic nephropathy mediated by P42/44MAPK.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney Function Tests; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Protective Agents; Random Allocation; Rats; Rats, Wistar | 2005 |
A new ATP-sensitive potassium channel opener protects the kidney from hypertensive damage in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; ATP-Binding Cassette Transporters; Benzazepines; Endothelin-1; Extracellular Matrix; Hemodynamics; Hypertension; Immunohistochemistry; KATP Channels; Kidney; Kidney Diseases; Kidney Function Tests; Potassium Channels, Inwardly Rectifying; Propylamines; Rats; Rats, Inbred SHR; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aspartic Acid Endopeptidases; Atrial Natriuretic Factor; Benzazepines; Benzofurans; Blood Pressure; Dose-Response Relationship, Drug; Endothelin-1; Endothelin-Converting Enzymes; Hypertension; Indoles; Male; Metalloendopeptidases; Neprilysin; Nitric Oxide; Organophosphonates; Phenylalanine; Protease Inhibitors; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species | 2005 |
Beneficial effects of combined benazepril-amlodipine on cardiac nitric oxide, cGMP, and TNF-alpha production after cardiac ischemia.
Topics: Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Calcium Channel Blockers; Cyclic GMP; Drug Therapy, Combination; Gene Expression Regulation; Interleukin-6; Male; Myocardial Ischemia; NF-kappa B; Nitric Oxide; Rats; Rats, Inbred Lew; RNA, Messenger; Tumor Necrosis Factor-alpha | 2006 |
Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis.
Topics: Amides; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Benzazepines; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Experimental; Endomyocardial Fibrosis; Fumarates; Insulin; Myocytes, Cardiac; Oxidative Stress; Rats; Renin; Tetrazoles | 2008 |
Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Disease Models, Animal; Female; Glycation End Products, Advanced; Hypertension; Kidney Cortex; Kidney Diseases; Male; NADPH Oxidases; Oxidative Stress; Phosphorylation; Platelet-Derived Growth Factor; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Signal Transduction; Transcription Factor RelA; Transforming Growth Factor beta1; Vascular Cell Adhesion Molecule-1 | 2009 |
Mitogen-activated protein kinase kinase 1/2 inhibition and angiotensin II converting inhibition in mice with cardiomyopathy caused by lamin A/C gene mutation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Benzimidazoles; Cardiomyopathy, Dilated; Lamin Type A; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Mutation; Treatment Outcome | 2014 |
Pharmacokinetic/Pharmacodynamic Modeling of Renin-Angiotensin Aldosterone Biomarkers Following Angiotensin-Converting Enzyme (ACE) Inhibition Therapy with Benazepril in Dogs.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Biomarkers; Biotransformation; Dogs; Female; Male; Models, Animal; Models, Biological; Nonlinear Dynamics; Peptidyl-Dipeptidase A; Protein Binding; Renin; Renin-Angiotensin System | 2015 |
Protective effects of valsartan and benazepril combined with atorvastatin on cardiorenal syndrome in rats.
Topics: Angiotensin II; Animals; Atorvastatin; Benzazepines; C-Reactive Protein; Cardio-Renal Syndrome; Case-Control Studies; Drug Synergism; Heptanoic Acids; Lipids; Male; Natriuretic Peptide, Brain; Proteinuria; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan | 2015 |
[Intervention of systolic pressure and left ventricular hypertrophy in rats under cold stress].
Topics: Angiotensin II; Animals; Benzazepines; Blood Pressure; Cold Temperature; Endothelin-1; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Rats; Rats, Inbred SHR; Stress, Physiological | 2016 |